17-β Estradiol attenuates hypoxic induction of HIF-1α and erythropoietin in Hep3B cells

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 1, 2004, Pages 93-100

  Mukundan, Harshini ^a   Kanagy, Nancy L ^a   Resta, Thomas C ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Immunofluorescence; Polycythemia; Real time PCR; Reporter gene activity; Western blot

Indexed keywords

ERYTHROPOIETIN; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSCRIPTION FACTOR;

ARTICLE; CELL HYPOXIA; CELL LINE; CELL STRAIN HEP3B; CONCENTRATION RESPONSE; DNA RESPONSIVE ELEMENT; ENHANCER REGION; GENE EXPRESSION REGULATION; HYPOXIA RESPONSE ELEMENT; IMMUNOFLUORESCENCE; NONHUMAN; POLYCYTHEMIA; PRIORITY JOURNAL; PROMOTER REGION; PULMONARY HYPERTENSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; WESTERN BLOTTING;

ANIMALS; ANOXIA; BLOTTING, WESTERN; CELLS, CULTURED; ERYTHROPOIETIN; ESTRADIOL; FLUORESCENT ANTIBODY TECHNIQUE; GENES, REPORTER; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; POLYMERASE CHAIN REACTION; RATS; TRANSCRIPTION FACTORS;

EID: 3042823278     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200407000-00013     Document Type: Article

References (33)

1. Fried R, Meyrick B, Rabinovitch M, et al. Polycythemia and the acute hypoxic response in awake rats following chronic hypoxia. J Appl Physiol. 1983;55:1167-1172.
2. Bauer C. The oxygen sensor that controls EPO production: facts and fancies. J Perinat Med. 1995;23:7-12.
3. Resta TC, Kanagy NL, Walker BR. Estradiol-induced attenuation of pulmonary hypertension is not associated with altered eNOS expression. Am J Physiol Lung Cell Mol Physiol. 2001;280:L88-L97.
4. Mukundan H, Resta TC, Kanagy NL. 17Beta-estradiol decreases hypoxic induction of erythropoietin gene expression. Am J Physiol Regul Integr Comp Physiol. 2002;283:R496-R504.
5. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 1992;12:5447-5454.
6. Hu J, Discher DJ, Bishopric NH, et al. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem Biophys Res Commun. 1998;245:894-899.
7. Beck I, Weinmann R, Caro J. Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-Kd nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood. 1993;82:704-711.
8. Huang LE, Arany Z, Livingston DM, et al. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem. 1996;271:32253-32259.
9. Earley S, Resta TC. Estradiol attenuates hypoxia-induced pulmonary endothelin-1 gene expression. Am J Physiol Lung Cell Mol Physiol. 2002; 283:L86-L93.
10. Goldberg MA, Glass GA, Cunningham JM, et al. The regulated expression of erythropoietin by two human hepatoma cell lines. Proc Natl Acad Sci USA. 1987;84:7972-7976.
11. Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1 alpha in vascular smooth muscle cells. J Biol Chem. 2000;275:26765-26771.
12. D'angelo G, Ladoux A, Frelin C. Hypoxia-induced transcriptional activation of vascular endothelial growth factor is inhibited by serum. Biochem Biophys Res Commun. 2000;267:334-338.
13. Butcher RL, Collins WE, Fugo NW. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology. 1974;94:1704-1708.
14. Lolmede K, Durand dSF, V, Galitzky J, et al. Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int J Obes Relat Metab Disord. 2003;27:1187-1195.
15. Opafil S, Chen SJ, Meng QC, et al. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat. Am J Physiol. 1995;268:L95-100.
16. Bonvallet ST, Zamora MR, Hasunuma K, et al. BQ123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats. Am J Physiol. 1994;266:H1327-H1331.
17. Chen SJ, Chen YF, Meng QC, et al. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J Appl Physiol. 1995;79:2122-2131.
18. Sato K, Morio Y, Morris KG, et al. Mechanism of hypoxic pulmonary vasoconstriction involves ET(A) receptor-mediated inhibition of K(ATP) channel. Am J Physiol Lung Cell Mol Physiol. 2000;278:L434-L442.
19. Sunyer J, Anto JM, Mcfarlane D, et al. Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:851-856.
20. Rabinovitch M, Gamble WJ, Miettinen OS, et al. Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am J Physiol. 1981;240:H62-H72.
21. McMurtry IF, Frith CH, Will DH. Cardiopulmonary responses of male and female swine to simulated high attitude. J Appl Physiol. 1973;35:459-462.
22. Miyamoto N, Mandai M, Takagi H, et al. Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP. Invest Ophthalmol Vis Sci. 2002;43:2007-2014.
23. Wiener CM, Booth G, Semenza GL. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun. 1996; 225:485-488.
24. Kallio PJ, Okamoto K, O'Brien S, et al. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. EMBO J. 1998;17:6573-6586.
25. Ebert BL, Bunn HF. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol Cell Biol. 1998;18:4089-4096.
26. Arany Z, Huang LE, Eckner R, et al. An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci U S A. 1996;93:12969-12973.
27. Kallio PJ, Wilson WJ, O'Brien S, et al. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem. 1999;274:6519-6525.
28. Mabjeesh NJ, Escuin D, LaVallee TM, et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell. 2003;3:363-375.
29. Bayard F, Clamens S, Meggetto F, et al. Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology. 1995;136:1523-1529.
30. Truss M, Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev. 1993;14:459-479.
31. Dubey RK, Jackson EK. Cardiovascular protective effects of 17beta-estradiol metabolites. J Appl Physiol. 2001;91:1868-1883.
32. Wakeling AE. Similarities and distinctions in the mode of action of different classes of antioestrogens. Endocr Relat Cancer. 2000;7:17-28.
33. Wakeling AE, Bowler J. Development of novel oestrogen-receptor antagonists. Biochem Soc Trans. 1991;19:899-901.